re: Ann: QRxPharma Resubmits MOXDUO New Drug ... Being an...

  1. 130 Posts.
    re: Ann: QRxPharma Resubmits MOXDUO New Drug ... Being an eternal optomist and sometime collector I really am going to frame that announcement for posterity along with my first ever cheque from HI.

    Right now the $1.00, imo puts QRX at the risk invited/risk adverse crossroads:
    Risk invited: this is a 5 bagger + stock if success with FDA.
    Risk adverse: get out while you still can.

    And I'm definitely not selling.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.